Bliss GVS Pharma Share Price

Bliss GVS Pharma Limited is engaged in developing, manufacturing, and marketing pharmaceutical formulations. The Company’s product categories include pharma products, other healthcare products, and therapeutic index. Its pharma products include pharma products include capsules, creams, gels, ointments, dry powder for injection, effervescent tablets, eye/ear drops, nasal solution, lotions, lozenges, oral solids, and others. The Company’s other healthcare products include balm, nasal inhaler, solution, soap, roll on, shampoo, powder, spray, and petroleum jelly. Its brands include ANOMEX, ANOMEX DS, CONLAX 5/10, G - ALFENAC 100, GACET 80/125/170/250/500/1G, GMETH - 50/100, GSUNATE - 50/100/200, GVCAM - 7.5/15, GV-SOFT 1/2/3/4 G, LOFNAC - 12.5/25/50/100, MEFINOL, MELANEZ, MENINA - 25/100, TYRIDOL, VIGOTAMIN, COMIT 50, BG - CLIND, VAGID CL, ECOZOLE, GVGYL 500, GYNANFORT, GVGYL N, KLOVINAL, LONART, LONART FORTE, LONART Dispersible, FINMOL, GACET-500, NOVOGLIP-5, GVZOLE, and DOXYCYCLINE.As of 25 May 2026, Bliss GVS Pharma share price is ₹317.55. The stock opened at ₹322.35, compared to its previous close of ₹300.35. During today's trading session, Bliss GVS Pharma share price moved in the range of ₹305.10 to ₹329.20, with an average price of ₹317.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹305.10 and a high of ₹329.20. On the performance front, Bliss GVS Pharma share price has increased by 87.97% over the last six months and is up 138.05% on a year-on-year basis.

The market capitalization of Bliss GVS Pharma is ₹3,176 Crs, with a P/E ratio of 23.6 and a dividend yield of 0.50%.